Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Churchill Capital Corp XI - Class A Ordinary Shares
(NQ:
CCXI
)
17.81
+0.36 (+2.06%)
Streaming Delayed Price
Updated: 2:20 PM EDT, Jul 1, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Churchill Capital Corp XI - Class A Ordinary Shares
< Previous
1
2
3
4
5
6
7
8
9
Next >
Is It Too Late to Buy ChemoCentryx Stock?
↗
October 14, 2021
The stock surged after obtaining FDA approval for avacopan.
Via
The Motley Fool
2 Super-Charged Growth Stocks to Buy Now
↗
October 13, 2021
These two small drugmakers are poised for a long-winded growth spurt.
Via
The Motley Fool
45 Biggest Movers From Yesterday
↗
October 13, 2021
Gainers ESSTech Inc (NYSE: GWH) shares surged 128.4% to close at $23.80 onTuesday. ESS Inc, the Bill Gates-backed battery maker went public on the NewYork Stock Exchange on...
Via
Benzinga
BZ Chart Of The Day: ChemoCentryx
↗
October 11, 2021
There’s an old saying on Wall Street that "gaps refill." It's true and it may be about to happen to shares of ChemoCent...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For October 11, 2021
↗
October 11, 2021
Upgrades According to Vertical Research, the prior rating for C.H. Robinson Worldwide Inc (NASDAQ:
Via
Benzinga
Thinking About Buying Stock In Starbucks, Peloton Or ChemoCentryx?
↗
October 11, 2021
One of the most common questions traders have about stocks is “Why Is It Moving?” That’s why Benzinga created the Why Is It Moving, or WIIM, feature in...
Via
Benzinga
Futures Slide As Soaring Oil Nears $85
↗
October 11, 2021
While cash bonds may be closed, one can easily extrapolate where they would be trading based on TSY futures which are currently trading at a 1.65% equivalent.
Via
Talk Markets
Topics
Bonds
10 Biggest Price Target Changes For Monday
↗
October 11, 2021
Keybanc lifted Netflix, Inc. (NASDAQ: NFLX) price target from $645 to $670. Netflix shares rose 0.1% to $633.00 in pre-market trading. JMP Securities raised ServiceNow, Inc. (...
Via
Benzinga
A Peek Into The Markets: US Stock Futures Down; Crude Oil Jumps 2%
↗
October 11, 2021
Pre-open movers U.S. stock futures traded lower in early pre-market trade after the Nasdaq dropped around 75 points in the previous session. Futures for the Dow Jones Industrial...
Via
Benzinga
Topics
Stocks
35 Biggest Movers From Friday
↗
October 11, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares surged 96% to close at $38.41 on Friday. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for...
Via
Benzinga
5 Stocks To Watch For October 11, 2021
↗
October 11, 2021
Some of the stocks that may grab investor focus today are: Mandiant Inc (NASDAQ: MNDT) reported the completion of divestiture of its FireEye Products unit to McAfee Enterprise...
Via
Benzinga
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
↗
October 10, 2021
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive stocks and into risky bets...
Via
Talk Markets
The Week Ahead In Biotech (Oct. 10-16): Avadel FDA Decision, Conference Presentations And IPOs Take Center Stage
↗
October 10, 2021
Biotech stocks retreated in the week ending Oct. 8, extending losses for the third straight week. Some of the selling in the space was due to money moving out of defensive...
Via
Benzinga
Why ChemoCentryx Stock Skyrocketed Today
↗
October 08, 2021
Investors are excited about the biotech's game-changing new drug.
Via
The Motley Fool
Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher
↗
October 08, 2021
Toward the end of trading Friday, the Dow traded up 0.24% to 34,835.06 while the NASDAQ fell 0.13% to 14,635.04. The S&P also rose, gaining 0.13% to 4,405.69. The U.S. has the...
Via
Benzinga
Topics
Stocks
ChemoCentryx, Allogene Show the Risks and Rewards of Nasdaq Biotech Stocks
↗
October 08, 2021
The broader market was mixed on Friday.
Via
The Motley Fool
Topics
Stocks
12 Health Care Stocks Moving In Friday's Intraday Session
↗
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) stock increased by 70.43% to $33.41 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 74.6...
Via
Benzinga
Mid-Day Market Update: Crude Oil Rises 2%; Allogene Therapeutics Shares Plunge
↗
October 08, 2021
Midway through trading Friday, the Dow traded down 0.06% to 34,734.52 while the NASDAQ fell 0.25% to 14,617.60. The S&P also fell, dropping 0.08% to 4,396.09. The U.S. has the...
Via
Benzinga
Topics
Stocks
EXCLUSIVE: ChemoCentryx Plans To Start Phase 3 Avacopan Trial In Chronic Skin Disorder In 2022
↗
October 08, 2021
After a tight advisory committee vote back in May tilted just slightly in favor of approving ChemoCentryx Inc's (NASDAQ: CCXI) avacopan, the FDA has cleared the drug...
Via
Benzinga
28 Stocks Moving In Friday's Mid-Day Session
↗
October 08, 2021
Gainers ChemoCentryx, Inc. (NASDAQ: CCXI) shares climbed 60.8% to $31.51. The FDA approved ChemoCentryx’s Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil...
Via
Benzinga
CCXI Stock: The Big FDA News That Has ChemoCentryx Shares Skyrocketing 60%
↗
October 08, 2021
CCXI stock is making its investors very happy this morning with some huge gains. It's receiving FDA approval for a rare disease treatment.
Via
InvestorPlace
Mid-Morning Market Update: Markets Edge Higher; US Economy Adds 194,000 Jobs In September
↗
October 08, 2021
Following the market opening Friday, the Dow traded up 0.12% to 34,796.95 while the NASDAQ rose 0.09% to 14,667.44. The S&P also rose, gaining 0.16% to 4,406.93. The U.S. has...
Via
Benzinga
Topics
Economy
Stocks
12 Health Care Stocks Moving In Friday's Pre-Market Session
↗
October 08, 2021
Gainers ChemoCentryx (NASDAQ:CCXI) shares rose 77.65% to $34.82 during Friday's pre-market session. The company's market cap stands at $2.4 billion. eFFECTOR...
Via
Benzinga
Why Did ChemoCentryx Shares Soar 70% On Friday Premarket?
↗
October 08, 2021
The FDA has approved ChemoCentryx Inc's (NASDAQ: CCXI) Tavneos (avacopan) as an adjunctive treatment for anti-neutrophil cytoplasmic autoantibody-associated...
Via
Benzinga
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs, And More
↗
October 03, 2021
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Here are the key catalysts that could move stocks in the unfolding...
Via
Talk Markets
The Week Ahead In Biotech (Oct. 3-9): ChemoCentryx FDA Decision, Conference Presentations, IPOs And More
↗
October 03, 2021
Biotech stocks came under pressure in the week ending Oct. 1, dragged by broader market weakness and the selling of vaccine stocks. Positive tidings from Merck & Co...
Via
Benzinga
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
↗
October 08, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 7) Alkermes plc (NASDAQ: ALKS)...
Via
Benzinga
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
↗
October 07, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 6) Enanta Pharmaceuticals, Inc...
Via
Benzinga
Attention Biotech Investors: Mark Your Calendar For October PDUFA Dates
↗
October 01, 2021
Following a mixed month for regulatory approvals, biotech investors now turn toward a month of plenty as far as Food and Drug Administration decisions are concerned. Four new...
Via
Benzinga
51 Biggest Movers From Yesterday
↗
October 01, 2021
Gainers Superior Drilling Products, Inc. (NYSE: SDPI) shares rose 60.6% to close at $1.75 on Thursday after jumping over 23% on Wednesday. The company, last month, reported Q2...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.